Target
Galactokinase
Ligand
BDBM249797
Substrate
n/a
Meas. Tech.
qHTS Assay
IC50
7491.6±n/a nM
Citation
 Boxer, MBWalsh, MJLiu, LTanega, CDShen, MLai, KTang, MAuld, DS Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders US Patent  US9447087 Publication Date 9/20/2016 
Target
Name:
Galactokinase
Synonyms:
GALK | GALK1 | GALK1_HUMAN | Galactokinase | Galactokinase (GALK) | Galactose kinase
Type:
Enzyme
Mol. Mass.:
42271.26
Organism:
Homo sapiens (Human)
Description:
P51570
Residue:
392
Sequence:
MAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGKESLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL
  
Inhibitor
Name:
BDBM249797
Synonyms:
US9447087, 27
Type:
Small organic molecule
Emp. Form.:
C19H19BrN4O2
Mol. Mass.:
415.284
SMILES:
Brc1ccc2oc(NC3=NC4(CCCC4)C4=C(CCCC4=O)N3)nc2c1 |t:8,16|
Structure:
Search PDB for entries with ligand similarity: